Breast Cancer Clinical Trial
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
Summary
Participants will be sent 3 surveys via email and a final brief survey conducted by email or phone. The four surveys will be collected 1) upon enrollment and prior to the primary care appointment; 2) following the primary care appointment; 3) 3 months after enrollment; 4) 1 year after enrollment. The final 2 surveys will offer an increased incentive to increase retention rates.
Full Description
Participants will be sent 3 surveys via email and a final brief survey conducted by email or phone. The four surveys will be collected 1) upon enrollment and prior to the primary care appointment; 2) following the primary care appointment; 3) 3 months after enrollment; 4) 1 year after enrollment. The final 2 surveys will offer an increased incentive to increase retention rates. Time 1 will be an online survey (REDS survey) that addresses Aim 1. Time 2 will present a brief summary of mammography evidence as a reminder for the participant. Participants will repeat the REDS survey. Time 2 will additionally assess the following: 1. Whether screening was discussed with the provider. 2. If screening was not discussed, why not (e.g. did not want to, no time, other pressing issues, etc.). 3. If screening was discussed, (a) what was discussed (i.e. benefits, false positives, overdiagnosis), (b) overall satisfaction with the discussion, (c) whether the provider offered a screening recommendation, (d) open-ended qualitative response eliciting how the discussion went. 4. Whether discussed the BCS-DA with anyone else (e.g., friends or family). 5. Patient activation. 6. Preferred role in decision-making. 7. Perceived barriers to screening. Finally, participants' information environment will be assessed using questions from Pearlman et al. (1997), 8. information seeking (e.g. to what extent the participant valued opinions from the provider, friends, and family), 9. information sharing and communication (e.g. screening attitudes of friends and family), and 10. perception of self as disseminator of mammography-related information. Time 3 and Time 4 (at 3 and 1 year, respectively) will repeat the summary of mammography evidence and measures from Time 2. Additionally, the team will assess whether screening was received up to one year after study enrollment using the participant's electronic medical record.
Eligibility Criteria
Inclusion Criteria:
Individuals who identify as female at birth
Ages 39-49 years old (inclusive) at the time of consent
English literacy
Internet access
No prior diagnosis of breast cancer, ductal carcinoma in situ (DCIS, also known as "stage zero breast cancer"), or lobular carcinoma in situ
No known BCRA1/2 gene mutation
Exclusion Criteria:
Individuals who identify other than female at birth
Individuals who are currently pregnant
Individuals < 39 years old or 50 years old and > at the time of consent
Lack English literacy
Lack of internet access
Prior diagnosis of breast cancer, ductal carcinoma in situ (DCIS, also known as "stage zero breast cancer"), or lobular carcinoma in situ
Known BCRA1/2 gene mutation
Decisionally Challenged Individuals
Prisoners or those on alternative sentencing or probation
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
How clear is this clinincal trial information?